Olmesartan as an add-on to Amlodipine in Hypertension

NCT00220233 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

632

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: olmesartan medoxomil
DRUG: amlodipine
DRUG: hydrochlorothiazide

Sponsor

Sankyo Pharma Gmbh